Recent advances in our understanding of the multifaceted clinical, molecular, and genetic underpinnings of EOAD have highlighted the complexity and nuances of how amyloid and tau interact with brain structure and function to produce a strikingly heterogenous array of EOAD phenotypes which variably overlap with LOAD. Here, MAPT is linked to amyloidosis.